Organic Letters
Letter
Rev. 2009, 109, 2505. (d) Desimoni, G.; Faita, G.; Jørgensen, K. A.
Chem. Rev. 2011, 111, PR284.
In summary, we have proved that C2-symmmetric chiral
bisoxazolines can be employed as small-molecule hydrogen-
bond-acceptor catalysts for enantioselective synthesis. The
development of an organocatalytic asymmetric decarboxylative
aldol reaction of β-carbonyl acids with trifluoroacetaldehyde
hemiacetals is especially notable given the high enantioselec-
tivity and the demonstrable applicability of this method to the
facile synthesis of biologically active agents. This study should
encourage further development of novel asymmetric trans-
formations by directly using C2-symmmetric chiral bisoxazo-
lines as organocatalysts. We also anticipate that the hydrogen-
bond-acceptor catalysis will open a new avenue for
enantioselective synthesis.
(6) Akalay, D.; Durner, G.; Gobel, M. W. Eur. J. Org. Chem. 2008,
̈
̈
2008, 2365.
(7) For reviews, see: (a) Wiley, R. H.; Bennett, L. L., Jr. Chem. Rev.
1949, 44, 447. (b) Frump, J. A. Chem. Rev. 1971, 71, 483. For the pKa
of 2-methyloxazoline, see: (c) Weinberger, M. A.; Greenhalgh, R. Can.
J. Chem. 1963, 41, 1038. Theoretical calculations suggest that the
nitrogen atom of oxazoline is a much stronger hydrogen-bond
acceptor than the oxygen atom. See: Bohm, H.-J.; Klebe, G.; Brode, S.;
̈
Hesse, U. Chem. - Eur. J. 1996, 2, 1509.
(8) For reviews of asymmetric decarboxylative reactions of β-
carbonyl acids, see: (a) Pan, Y.; Tan, C.-H. Synthesis 2011, 2011, 2044.
(b) Wang, Z.-L. Adv. Synth. Catal. 2013, 355, 2745. (c) Nakamura, S.
Org. Biomol. Chem. 2014, 12, 394.
(9) For decarboxylative aldol reactions of β-keto acids, see: (a) Rohr,
K.; Mahrwald, R. Org. Lett. 2011, 13, 1878. (b) Zheng, Y.; Xiong, H.-
Y.; Nie, J.; Hua, M.-Q.; Ma, J.-A. Chem. Commun. 2012, 48, 4308.
(c) Zhong, F.; Yao, W.; Dou, X.; Lu, Y. Org. Lett. 2012, 14, 4018.
(d) Suh, C. W.; Chang, C. W.; Choi, K. W.; Lim, Y. J.; Kim, D. Y.
Tetrahedron Lett. 2013, 54, 3651. (e) Zhong, F.; Jiang, C.; Yao, W.; Xu,
L.-W.; Lu, Y. Tetrahedron Lett. 2013, 54, 4333. (f) Duan, Z.; Han, J.;
Qian, P.; Zhang, Z.; Wang, Y.; Pan, Y. Org. Biomol. Chem. 2013, 11,
6456. (g) Duan, Z.; Han, J.; Qian, P.; Zhang, Z.; Wang, Y.; Pan, Y.
Beilstein J. Org. Chem. 2014, 10, 969. (h) Ren, N.; Nie, J.; Ma, J.-A.
ASSOCIATED CONTENT
■
S
* Supporting Information
The Supporting Information is available free of charge on the
Experimental details and NMR data for all new
AUTHOR INFORMATION
(10) (a) Kirsch, P. Modern Fluoroorganic Chemistry: Synthesis,
Reactivity, Applications; Wiley-VCH: Weinheim, Germany, 2004.
■
Corresponding Author
ORCID
(b) Muller, K.; Faeh, C.; Diederich, F. Science 2007, 317, 1881.
̈
(c) Wang, J.; Sanchez-Rosello, M.; Acena, J. L.; del Pozo, C.;
́
́
̃
Sorochinsky, A. E.; Fustero, S.; Soloshonok, V. A.; Liu, H. Chem. Rev.
2014, 114, 2432.
Notes
(11) (a) Rabasseda, X.; Sorbera, L. A.; Castaner, J. Drugs Future
̃
1999, 24, 1057. (b) Ishii, A.; Kanai, M.; Higashiyama, K.; Mikami, K.
Chirality 2002, 14, 709. (c) Kawai, H.; Tachi, K.; Tokunaga, E.; Shiro,
M.; Shibata, N. Angew. Chem., Int. Ed. 2011, 50, 7803. (d) Huang, Y.-
Y.; Yang, X.; Chen, Z.; Verpoort, F.; Shibata, N. Chem. - Eur. J. 2015,
21, 8664.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
(12) (a) Funabiki, K.; Yamamoto, H.; Nagaya, H.; Matsui, M.
Tetrahedron Lett. 2006, 47, 5507. (b) Zhang, F.; Peng, Y.; Liao, S.;
Gong, Y. Tetrahedron 2007, 63, 4636. (c) Funabiki, K.; Itoh, Y.;
Kubota, Y.; Matsui, M. J. Org. Chem. 2011, 76, 3545. (d) Cotman, A.
E.; Cahard, D.; Mohar, B. Angew. Chem., Int. Ed. 2016, 55, 5294.
(13) Bisoxazolines I−VII were directly purchased and used without
further purification. VIII and IX were synthesized according to the
literature. See: (a) Liu, B.; Zhu, S.-F.; Zhang, W.; Chen, C.; Zhou, Q.-
L. J. Am. Chem. Soc. 2007, 129, 5834. (b) Zhu, S.-F.; Song, X.-G.; Li,
Y.; Cai, Y.; Zhou, Q.-L. J. Am. Chem. Soc. 2010, 132, 16374.
(14) Mitsunobu, O.; Yamada, Y. Bull. Chem. Soc. Jpn. 1967, 40, 2380.
(b) Mitsunobu, O. Synthesis 1981, 1981, 1. (c) Swamy, K. C.; Kumar,
N. N.; Balaraman, E.; Kumar, K. V. Chem. Rev. 2009, 109, 2551.
This work was supported financially by the National Natural
Science Foundation of China (21225208, 21472137, and
21532008), the National Basic Research Program of China
(973 Program) (2014CB745100), and the Tianjin Municipal
Science & Technology Commission (14JCZDJC33400).
Professor Qi-Lin Zhou (Nankai University) is gratefully
acknowledged for kindly providing chiral spiro-bisoxazolines.
REFERENCES
■
(1) Pauling, L. The Nature of the Chemical Bond; Cornell University
Press: Ithaca, NY, 1960.
(2) (a) Jeffrey, G. A.; Saenger, W. Hydrogen Bonding in Biological
Structures; Springer: Berlin, 1991. (b) Desiraju, G. R.; Steiner, T. The
Weak Hydrogen Bond in Structural Chemistry and Biology; Oxford
University Press: Oxford, U.K., 1999.
(3) For selected reviews, see: (a) Schreiner, P. R. Chem. Soc. Rev.
2003, 32, 289. (b) Taylor, M. S.; Jacobsen, E. N. Angew. Chem., Int. Ed.
2006, 45, 1520. (c) Doyle, A. G.; Jacobsen, E. N. Chem. Rev. 2007,
107, 5713. (d) Yu, X.; Wang, W. Chem. - Asian J. 2008, 3, 516.
(4) For selected reviews, see: (a) List, B. Acc. Chem. Res. 2004, 37,
548. (b) Notz, W.; Tanaka, F.; Barbas, C. F., III Acc. Chem. Res. 2004,
37, 580. (c) Dalko, P. I.; Moisan, L. Angew. Chem., Int. Ed. 2004, 43,
5138. (d) Lelais, G.; MacMillan, D. W. C. Aldrichimica Acta 2006, 39,
́
79. (e) Palomo, C.; Oiarbide, M.; Lopez, R. Chem. Soc. Rev. 2009, 38,
632. (f) Dalko, P. I. Comprehensive Enantioselective Organocatalysis:
Catalysts, Reactions, and Applications; Wiley-VCH: Weinheim,
Germany, 2013.
(5) For reviews, see: (a) Ghosh, A. K.; Mathivanan, P.; Cappiello, J.
Tetrahedron: Asymmetry 1998, 9, 1. (b) Rechavi, D.; Lemaire, M.
Chem. Rev. 2002, 102, 3467. (c) Hargaden, G. C.; Guiry, P. J. Chem.
D
Org. Lett. XXXX, XXX, XXX−XXX